Cardiac transcription factors driven lineage-specification of adult stem cells.

Fecha de publicación:

Autores de IIS La Fe

Abstract

Differentiation of human bone marrow mesenchymal stem cells (hBMSC) into the cardiac lineage has been assayed using different approaches such as coculture with cardiac or embryonic cells, treatment with factors, or by seeding cells in organotypic cultures. In most cases, differentiation was evaluated in terms of expression of cardiac-specific markers at protein or molecular level, electrophysiological properties, and formation of sarcomers in differentiated cells. As observed in embryonic stem cells and cardiac progenitors, differentiation of MSC towards the cardiac lineage was preceded by translocation of NKX2.5 and GATA4 transcription factors to the nucleus. Here, we induce differentiation of hBMSC towards the cardiac lineage using coculture with neonatal rat cardiomyocytes. Although important ultrastructural changes occurred during the course of differentiation, sarcomerogenesis was not fully achieved even after long periods of time. Nevertheless, we show that the main cardiac markers, NKX2.5 and GATA4, translocate to the nucleus in a process characteristic of cardiac specification.

Datos de la publicación

ISSN/ISSNe:
1937-5387, 1937-5395

Journal of cardiovascular translational research  Springer

Tipo:
Article
Páginas:
61-65
PubMed:
20560034
Factor de Impacto:
0,218 SCImago
Cuartil:
Q3 SCImago

Citas Recibidas en Web of Science: 15

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Proyectos y Estudios Clínicos

REDINSCOR

RD06/0003/1001 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2008

NEUROBLASTO VAL: INVESTIGACION BASICA Y TRASLACIONAL DE LA TERAPIA DEL NEUROBLASTOMA DE ALTO RIESGO.

Investigador Principal: VICTORIA CASTEL SÁNCHEZ

41/09 . GENT PER GENT . 2010

RED DE BIOBANCOS (BIOBANCOS)

RD09/0076/00021 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2010

CREACION Y MEJORA DE INFRAESTRUCTURAS EN MEDICINA REGENERATIVA

Investigador Principal: FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA

PLE2009-0141 ACI-PLAN E . MINISTERIO DE CIENCIA E INNOVACION; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2009

ENSAYO MULTICENTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE LA REPOSICION DE FXIII CON DOS DOSIS DIFERENTES DE FACTOR XIII RECOMBINANTE TRAS CIRUGIA DE DERIVACION CARDIOPULMONAR

Investigador Principal: JOSÉ ANASTASIO MONTERO ARGUDO

NN1810-3540 . 2009

Cita

Compartir